86 related articles for article (PubMed ID: 20546276)
1. Autoantibodies to glial fibrillary acid protein and S100beta in diabetic patients.
Gómez-Touriño I; Camiña-Darriba F; Otero-Romero I; Rodríguez MA; Hernández-Fernández A; González-Fernández A; Pena-González E; Rodríguez J; Rodríguez-Segade S; Varela-Calvino R
Diabet Med; 2010 Feb; 27(2):246-8. PubMed ID: 20546276
[No Abstract] [Full Text] [Related]
2. [Nervous tissue protein autoantibodies in hepatolenticular degeneration].
Morozov SG; Usanova MP; Poleshchuk VV; Poletaev AV; Ivanova-Smolenskaia IA; Markova ED
Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(10):37-9. PubMed ID: 11712267
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive.
Winer S; Tsui H; Lau A; Song A; Li X; Cheung RK; Sampson A; Afifiyan F; Elford A; Jackowski G; Becker DJ; Santamaria P; Ohashi P; Dosch HM
Nat Med; 2003 Feb; 9(2):198-205. PubMed ID: 12539039
[TBL] [Abstract][Full Text] [Related]
4. [Antibodies against nerve tissue proteins S100, GFAP, and MP65 and pregnant women with early toxemia].
Morozov SG; Poletaev AB; Murashko LE; D'iakova EP; Ponomareva IV; Gnedenko BB; Sukhikh GT
Vopr Med Khim; 1998; 44(6):576-83. PubMed ID: 10599145
[TBL] [Abstract][Full Text] [Related]
5. [Changes in level of serum IgG autoantibodies to nerve tissue proteins in patients with life-threatening arrhythmias].
Kliushnik TP; Danilovskaia EV; Vatolkina OE; Shkol'nikova MA; Bereznitskaia VV; Poletaev AB; Vabishchevich NK
Biull Eksp Biol Med; 1998 Jun; 125(6):677-9. PubMed ID: 9693766
[No Abstract] [Full Text] [Related]
6. [Clinico-immunologic aspects of diabetes mellitus].
Esenin VI; Zlobina EN; Demin IuM; Dedov II
Sov Med; 1990; (3):100-1. PubMed ID: 2195666
[No Abstract] [Full Text] [Related]
7. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.
Antonelli A; Tuomi T; Nannipieri M; Fallahi P; Nesti C; Okamoto H; Groop L; Ferrannini E
Diabetologia; 2002 Sep; 45(9):1298-306. PubMed ID: 12242463
[TBL] [Abstract][Full Text] [Related]
8. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
Goel A; Chiu H; Felton J; Palmer JP; Brooks-Worrell B
Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222
[TBL] [Abstract][Full Text] [Related]
9. [Immunochemical correlates of the severity of Parkinson's disease].
Morozov SG; Ivanova-Smolenskaia IA; Markova ED; Piradov MA; Poleshchuk VV; Labunskiĭ DA; Gnedenko BB
Vopr Med Khim; 1997; 43(1):34-8. PubMed ID: 9281224
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of S100beta and glial fibrillary acidic protein in the hippocampus after kainic acid-induced lesions and mossy fiber sprouting in adult rat.
Bendotti C; Guglielmetti F; Tortarolo M; Samanin R; Hirst WD
Exp Neurol; 2000 Jan; 161(1):317-29. PubMed ID: 10683297
[TBL] [Abstract][Full Text] [Related]
12. Collagen binding activity in sera of patients with insulin-dependent (type 1) and non insulin-dependent (type 2) diabetes mellitus.
Triolo G; Giardina E; Bompiani GD
J Clin Lab Immunol; 1988 Jul; 26(3):121-4. PubMed ID: 3230579
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of glomerulonephritis and autoantibodies in diabetes mellitus.
Bhuyan UN; Dash SC; Srikanta S; Malaviya AN; Malhotra KK
J Assoc Physicians India; 1984 Feb; 32(2):171-5. PubMed ID: 6235208
[No Abstract] [Full Text] [Related]
14. Autoantibody to glial fibrillary acidic protein in the sera of cattle with bovine spongiform encephalopathy.
Nomura S; Miyasho T; Maeda N; Doh-ura K; Yokota H
Proteomics; 2009 Aug; 9(16):4029-35. PubMed ID: 19658106
[TBL] [Abstract][Full Text] [Related]
15. [Markers of inflammation, autoantibodies to neurospecific antigens and outcome in patients with acute ischemic stroke].
Ruleva NIu; Kuzin VM; Martynov MIu; Kamchatnov PR; Liukova TK; Chugunov AV; Dugin SF; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 12):60-5. PubMed ID: 15628589
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD38 autoantibodies in type? diabetes.
Mallone R; Perin PC
Diabetes Metab Res Rev; 2006; 22(4):284-94. PubMed ID: 16544364
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
[TBL] [Abstract][Full Text] [Related]
18. Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia.
Mecocci P; Parnetti L; Romano G; Scarelli A; Chionne F; Cecchetti R; Polidori MC; Palumbo B; Cherubini A; Senin U
J Neuroimmunol; 1995 Mar; 57(1-2):165-70. PubMed ID: 7706432
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to REG, a beta-cell regeneration factor, in diabetic patients.
Shervani NJ; Takasawa S; Uchigata Y; Akiyama T; Nakagawa K; Noguchi N; Takada H; Takahashi I; Yamauchi A; Ikeda T; Iwamoto Y; Nata K; Okamoto H
Eur J Clin Invest; 2004 Nov; 34(11):752-8. PubMed ID: 15530148
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to neuron-specific proteins S100, GFAP, MBP and NGF in the serum of rats with streptozotocin-induced diabetes.
Lotosh NG; Savel'eva EK; Selishcheva AA; Savel'ev SV
Bull Exp Biol Med; 2013 May; 155(1):48-51. PubMed ID: 23667870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
